Podcast Episodes
Back to Search
COVID Reflections, Novo’s Next-Gen Weight Loss Struggles, Another Depression Miss, More
As we mark five years since the World Health Organization officially declared the COVID-19 pandemic, the BioSpace editorial team reflects on the heal…
1 year, 3 months ago
Tariff Threat Continues, More Meetings Cancelled, AbbVie Makes Obesity Play, More
Donald Trump’s tariffs have headlined myriad news stories this week—including at BioSpace, where we reported Pfizer CEO Albert Bourla’s claim that hi…
1 year, 4 months ago
A Conversation With Kevin Marks, CEO of Delphia
On the sidelines of this year’s J.P. Morgan Healthcare Conference in San Francisco, BioSpace Senior Editor Annalee Armstrong sat down with Kevin Mark…
1 year, 4 months ago
Money Meets Medicine: A Disruptor's Guide to Life Sciences Investment
Miruna Sasu, CEO of COTA, has been labeled as a disrupter in the industry. In this discussion, she highlights the challenges of investing in the life…
1 year, 4 months ago
Trump’s Pharma Tariffs, Another GLP-1 Compounding Lawsuit, Bluebird’s Bailout, More
There was a high point this week for employees riding the rollercoaster that is currently the FDA, as 300 recently fired employees are reportedly bei…
1 year, 4 months ago
Examining Gene Therapies, Bispecific Antibodies and Other Novel Modalities
At the 2025 National Biotechnology Conference, gene therapies, bispecific antibodies and other novel modalities—relative newcomers to medicine—will b…
1 year, 4 months ago
Trump’s Hammer Hits FDA, Moderna Falls Further and Patent Cliffs Loom
President Trump has been on a staff cutting rampage since taking office, and this weekend, the hammer came down on an undisclosed number of FDA emplo…
1 year, 4 months ago
A Conversation With Dannielle Appelhans, CEO of COUR
On the sidelines of this year’s J.P. Morgan Healthcare Conference in San Francisco, BioSpace Senior Editor Annalee Armstrong sat down with Dannielle …
1 year, 4 months ago
Navigating Patient Journeys with Tom Whitehead
BioSpace’s Head of Insights Lori Ellis and Tom Whitehead, co-founder of the Emily Whitehead Foundation discuss the challenges navigated by cancer pat…
1 year, 4 months ago
New M&A Action, BMS’ Ongoing Cost Cuts and the Insatiable Demand for Weight Loss Drugs
We saw more action on the M&A front this week as Novartisbought back its blood thinner abelacimab and the rest of Anthos Therapeutics for up to $3.1 …
1 year, 4 months ago